rs45575136

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000214.3(JAG1):​c.924C>T​(p.Asn308Asn) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0287 in 1,613,892 control chromosomes in the GnomAD database, including 933 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.025 ( 84 hom., cov: 32)
Exomes 𝑓: 0.029 ( 849 hom. )

Consequence

JAG1
NM_000214.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 0.0580

Publications

11 publications found
Variant links:
Genes affected
JAG1 (HGNC:6188): (jagged canonical Notch ligand 1) The jagged 1 protein encoded by JAG1 is the human homolog of the Drosophilia jagged protein. Human jagged 1 is the ligand for the receptor notch 1, the latter is involved in signaling processes. Mutations that alter the jagged 1 protein cause Alagille syndrome. Jagged 1 signalling through notch 1 has also been shown to play a role in hematopoiesis. [provided by RefSeq, Nov 2019]
JAG1 Gene-Disease associations (from GenCC):
  • Alagille syndrome due to a JAG1 point mutation
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics, PanelApp Australia
  • Charcot-Marie-Tooth disease, axonal, Type 2HH
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • tetralogy of fallot
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.57).
BP6
Variant 20-10652213-G-A is Benign according to our data. Variant chr20-10652213-G-A is described in ClinVar as Benign. ClinVar VariationId is 42483.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.058 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.0658 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
JAG1NM_000214.3 linkc.924C>T p.Asn308Asn synonymous_variant Exon 7 of 26 ENST00000254958.10 NP_000205.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
JAG1ENST00000254958.10 linkc.924C>T p.Asn308Asn synonymous_variant Exon 7 of 26 1 NM_000214.3 ENSP00000254958.4
JAG1ENST00000423891.6 linkn.790C>T non_coding_transcript_exon_variant Exon 5 of 25 2
JAG1ENST00000617965.2 linkn.293C>T non_coding_transcript_exon_variant Exon 2 of 17 5

Frequencies

GnomAD3 genomes
AF:
0.0246
AC:
3743
AN:
152106
Hom.:
84
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00655
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.0689
Gnomad ASJ
AF:
0.00288
Gnomad EAS
AF:
0.0135
Gnomad SAS
AF:
0.0418
Gnomad FIN
AF:
0.0328
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0255
Gnomad OTH
AF:
0.0273
GnomAD2 exomes
AF:
0.0371
AC:
9328
AN:
251388
AF XY:
0.0348
show subpopulations
Gnomad AFR exome
AF:
0.00652
Gnomad AMR exome
AF:
0.108
Gnomad ASJ exome
AF:
0.00199
Gnomad EAS exome
AF:
0.0113
Gnomad FIN exome
AF:
0.0349
Gnomad NFE exome
AF:
0.0261
Gnomad OTH exome
AF:
0.0298
GnomAD4 exome
AF:
0.0291
AC:
42533
AN:
1461668
Hom.:
849
Cov.:
32
AF XY:
0.0290
AC XY:
21072
AN XY:
727142
show subpopulations
African (AFR)
AF:
0.00505
AC:
169
AN:
33476
American (AMR)
AF:
0.104
AC:
4652
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00226
AC:
59
AN:
26134
East Asian (EAS)
AF:
0.0169
AC:
671
AN:
39700
South Asian (SAS)
AF:
0.0422
AC:
3636
AN:
86256
European-Finnish (FIN)
AF:
0.0333
AC:
1780
AN:
53408
Middle Eastern (MID)
AF:
0.00780
AC:
45
AN:
5768
European-Non Finnish (NFE)
AF:
0.0270
AC:
30014
AN:
1111822
Other (OTH)
AF:
0.0250
AC:
1507
AN:
60382
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
2404
4809
7213
9618
12022
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1202
2404
3606
4808
6010
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0246
AC:
3747
AN:
152224
Hom.:
84
Cov.:
32
AF XY:
0.0259
AC XY:
1930
AN XY:
74448
show subpopulations
African (AFR)
AF:
0.00653
AC:
271
AN:
41524
American (AMR)
AF:
0.0693
AC:
1059
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.00288
AC:
10
AN:
3470
East Asian (EAS)
AF:
0.0137
AC:
71
AN:
5180
South Asian (SAS)
AF:
0.0412
AC:
199
AN:
4828
European-Finnish (FIN)
AF:
0.0328
AC:
348
AN:
10606
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0254
AC:
1731
AN:
68022
Other (OTH)
AF:
0.0270
AC:
57
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
182
364
545
727
909
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
48
96
144
192
240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0229
Hom.:
20
Bravo
AF:
0.0265
Asia WGS
AF:
0.0300
AC:
104
AN:
3478
EpiCase
AF:
0.0232
EpiControl
AF:
0.0243

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Apr 09, 2023
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 10, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

p.Asn308Asn in exon 7 of JAG1:This variant is not expected to have clinical sign ificance because it does not alter an amino acid residue and is not located with in the splice consensus sequence. It has been identified in 11% (1274/11536) of Latino chromosomes, including 73 homozygotes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs45575136). -

not provided Benign:2
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Isolated Nonsyndromic Congenital Heart Disease Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Alagille syndrome due to a JAG1 point mutation Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cardiovascular phenotype Benign:1
Jun 12, 2015
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.57
CADD
Benign
3.1
DANN
Benign
0.88
PhyloP100
0.058
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs45575136; hg19: chr20-10632861; COSMIC: COSV107294903; COSMIC: COSV107294903; API